196 related articles for article (PubMed ID: 36682514)
1. Treadmill workout activates PPARα in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease.
Rangasamy SB; Jana M; Dasarathi S; Kundu M; Pahan K
Brain Behav Immun; 2023 Mar; 109():204-218. PubMed ID: 36682514
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
3. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
4. Identification of Cinnamein, a Component of Balsam of Tolu/Peru, as a New Ligand of PPARα for Plaque Reduction and Memory Protection in a Mouse Model of Alzheimer's Disease.
McKay M; Gorai S; Paidi RK; Mondal S; Pahan K
J Alzheimers Dis Rep; 2024; 8(1):903-922. PubMed ID: 38910936
[TBL] [Abstract][Full Text] [Related]
5. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
6. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
Chandra S; Jana M; Pahan K
J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
[TBL] [Abstract][Full Text] [Related]
8. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.
Baranger K; Marchalant Y; Bonnet AE; Crouzin N; Carrete A; Paumier JM; Py NA; Bernard A; Bauer C; Charrat E; Moschke K; Seiki M; Vignes M; Lichtenthaler SF; Checler F; Khrestchatisky M; Rivera S
Cell Mol Life Sci; 2016 Jan; 73(1):217-36. PubMed ID: 26202697
[TBL] [Abstract][Full Text] [Related]
9. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
10. Prolonged isolation stress accelerates the onset of Alzheimer's disease-related pathology in 5xFAD mice despite running wheels and environmental enrichment.
Peterman JL; White JD; Calcagno A; Hagen C; Quiring M; Paulhus K; Gurney T; Eimerbrink MJ; Curtis M; Boehm GW; Chumley MJ
Behav Brain Res; 2020 Feb; 379():112366. PubMed ID: 31743728
[TBL] [Abstract][Full Text] [Related]
11. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
Cui H; King AE; Jacobson GA; Small DH
J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
Macyczko JR; Wang N; Lu W; Jeevaratnam S; Shue F; Martens Y; Liu CC; Kanekiyo T; Bu G; Li Y
J Alzheimers Dis; 2023; 95(2):399-405. PubMed ID: 37545238
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise promotes E3 ubiquitin ligase to remove amyloid β and P-tau and improve cognitive ability in APP/PS1 transgenic mice.
Xu L; Li M; Wei A; Yang M; Li C; Liu R; Zheng Y; Chen Y; Wang Z; Wang K; Wang T
J Neuroinflammation; 2022 Oct; 19(1):243. PubMed ID: 36195875
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
[TBL] [Abstract][Full Text] [Related]
15. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
Schroeder A; Fahrenholz F; Schmitt U
J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
[TBL] [Abstract][Full Text] [Related]
16. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
17. Muscle-building supplement β-hydroxy β-methylbutyrate binds to PPARα to improve hippocampal functions in mice.
Paidi RK; Raha S; Roy A; Pahan K
Cell Rep; 2023 Jul; 42(7):112717. PubMed ID: 37437568
[TBL] [Abstract][Full Text] [Related]
18. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
Sadleir KR; Popovic J; Vassar R
J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
[TBL] [Abstract][Full Text] [Related]
19. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.
Manzine PR; Ettcheto M; Cano A; Busquets O; Marcello E; Pelucchi S; Di Luca M; Endres K; Olloquequi J; Camins A; Cominetti MR
Biomed Pharmacother; 2019 May; 113():108661. PubMed ID: 30836275
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
